Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Programmed cell death protein 6 (PDCD6, also known as ALG-2) is a calcium-binding protein in the penta-EF-hand family that acts as an intracellular calcium sensor and adapter. Calcium binding triggers conformational changes allowing PDCD6 to modulate interactions between diverse protein partners involved in apoptosis, ER-Golgi transport, endosomal biogenesis, and membrane repair. PDCD6 participates in T cell receptor-, Fas-, and glucocorticoid-induced programmed cell death, although evidence from knockout mouse models suggests functional redundancy. PDCD6 also interacts with multiple signaling proteins (e.g., ASK1, Fas receptor, ANXA11) and regulates complexes in the ESCRT pathway, vesicular trafficking, and potentially angiogenesis or viral protein distribution. Disease associations include reported roles in cancer (ocular melanoma) and potentially in infection, with pleiotropic functions in various cellular compartments[1][2][3][5][6].
None documented for drugs, but mechanistically acts as a calcium sensor/adaptor; involved in calcium-dependent signaling relevant to apoptosis and trafficking
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Programmed cell death protein 6 (PDCD6).